Picture of Initiator Pharma A/S logo

INIT Initiator Pharma A/S News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Initiator Pharma Gets UK CTA Approval For Phase 2a Study

Nov 3 (Reuters) - Initiator Pharma A/S INIT.ST:

RECEIVES UK CTA APPROVAL TO INITIATE PHASE 2A STUDY IN VULVODYNIA

FIRST PATIENTS EXPECTED TO BE ENROLLED IN Q4 2025

Source text: ID:nMFN9fd3Lg

Further company coverage: INIT.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Initiator Pharma A/S

See all news